- Home
- PBBK vs HOWL Comparison
PBBK vs HOWL Comparison
Compare PBBK & HOWL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PBBK
- HOWL
- Stock Information
- Founded
- PBBK 1919
- HOWL 2017
- Country
- PBBK United States
- HOWL United States
- Employees
- PBBK N/A
- HOWL N/A
- Industry
- PBBK Banks
- HOWL Biotechnology: Pharmaceutical Preparations
- Sector
- PBBK Finance
- HOWL Health Care
- Exchange
- PBBK Nasdaq
- HOWL Nasdaq
- Market Cap
- PBBK 45.2M
- HOWL 53.4M
- IPO Year
- PBBK N/A
- HOWL 2021
- Fundamental
- Price
- PBBK $18.02
- HOWL $1.10
- Analyst Decision
- PBBK
- HOWL Strong Buy
- Analyst Count
- PBBK 0
- HOWL 3
- Target Price
- PBBK N/A
- HOWL $8.33
- AVG Volume (30 Days)
- PBBK 4.6K
- HOWL 648.5K
- Earning Date
- PBBK 08-13-2025
- HOWL 08-07-2025
- Dividend Yield
- PBBK N/A
- HOWL N/A
- EPS Growth
- PBBK 12.16
- HOWL N/A
- EPS
- PBBK 0.83
- HOWL N/A
- Revenue
- PBBK $12,804,000.00
- HOWL $1,143,000.00
- Revenue This Year
- PBBK N/A
- HOWL N/A
- Revenue Next Year
- PBBK N/A
- HOWL N/A
- P/E Ratio
- PBBK $22.57
- HOWL N/A
- Revenue Growth
- PBBK 5.21
- HOWL N/A
- 52 Week Low
- PBBK $13.85
- HOWL $0.60
- 52 Week High
- PBBK $19.05
- HOWL $4.18
- Technical
- Relative Strength Index (RSI)
- PBBK 66.45
- HOWL 46.17
- Support Level
- PBBK $16.49
- HOWL $1.18
- Resistance Level
- PBBK $19.05
- HOWL $1.30
- Average True Range (ATR)
- PBBK 0.59
- HOWL 0.12
- MACD
- PBBK 0.14
- HOWL -0.03
- Stochastic Oscillator
- PBBK 91.23
- HOWL 6.33
About PBBK PB Bankshares Inc.
PB Bankshares Inc follows a community bank model and provides multiple services to individuals and small to midsize businesses. Its business consists of attracting retail and commercial deposits from the general public in its market area and investing those deposits, together with funds generated from operations and borrowings, in commercial real estate loans, commercial and industrial loans, construction, home equity lines of credit and to a lesser extent, one- to four-family residential real estate loans and consumer loans.
About HOWL Werewolf Therapeutics Inc.
Werewolf Therapeutics Inc is a biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer. It is leveraging its proprietary PREDATOR platform to design conditionally activated molecules that stimulate both adaptive and innate immunity with the goal of addressing the limitations of conventional proinflammatory immune therapies. Its INDUKINE molecules are intended to remain inactive in peripheral tissue yet activate selectively in the tumor microenvironment or TME.